You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯環藥業(600513.SH)半年度淨利潤升6.93%至4136.79萬元
格隆匯 08-16 16:50

格隆匯8月16日丨聯環藥業(600513.SH)發佈2019年半年度報告,實現營業收入5.55億元,同比增長19.69%;歸屬於上市公司股東的淨利潤4136.79萬元,同比增長6.93%;歸屬於上市公司股東的扣除非經常性損益的淨利潤4073.69萬元,同比增長5.30%;基本每股收益0.14元。

上半年,為適應新形勢新要求,公司加快了機構機制改革,成立了信息調度中心和大宗物資採購辦公室,為更好的發揮科技人員作用,加快公司科技創新步伐,撤併了技術管理部,成立了藥物研究所;並分別對退城進園、新藥研發、投資發展、資金清欠、“三化”建設、新區GMP認證、大宗物資集中採購及招投標工作領導小組進行了人員調整,不斷強化組織領導,保障公司推行的各項改革落地生根。同時,完善了管理層及相關領導、中層、班組長以及各類技術人員的年度考核細則,新建了管理層月度重點工作考核方案,動真碰硬的進行考核,全面落實公司各個層級加快發展聯環的責任。

攻堅退城進園,一期二期全面完成。公司在科學組織老廠區原料藥和製劑產品生產備貨的同時,集中人力、物力、財力,全力攻堅退城進園。目前,一期、二期項目已全面完成,QC相關的產品分析方法轉移、現場儀器設備驗證確認等工作已經結束,固體制劑與小容量注射劑車間正在有條不紊地進行產品的工藝驗證和清潔驗證,兩個製劑車間計劃於今年11月份遞交GMP認證材料。公司目前正強有力地推進三期工程建設,公用管架、事故應急池等項目正集中力量進行趕工,原料藥車間和公用工程已進入全面安裝調試階段,567廠房計劃8月份投入驗證,12348廠房計劃9月份投入驗證。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account